Get the Stockscreener App
1.82
4.71%
-0.09
Pre-market:
1.80
-0.02
-1.10%
Sellas Life Sciences Group Inc stock is traded at $1.82, with a volume of 4.53M.
It is down -4.71% in the last 24 hours and up +13.04% over the past month.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
See More
Previous Close:
$1.91
Open:
$1.91
24h Volume:
4.53M
Relative Volume:
1.55
Market Cap:
$191.64M
Revenue:
-
Net Income/Loss:
$-37.34M
P/E Ratio:
-1.3382
EPS:
-1.36
Net Cash Flow:
$-36.91M
1W Performance:
-8.54%
1M Performance:
+13.04%
6M Performance:
+17.42%
1Y Performance:
+54.24%
1-Day Range:
$1.81
$1.93
1-Week Range:
$1.81
$2.12
52-Week Range:
$0.772
$2.48
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Name
Sellas Life Sciences Group Inc
Sector
Industry
Phone
(646) 200-5278
Address
7 TIMES SQUARE, NEW YORK, NY
Compare SLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.82 | 281.61M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-01-18 | Initiated | Oppenheimer | Outperform |
| Apr-02-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Upgrade | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Stock (SLS) Latest News
SELLAS Life Sciences Group Inc. stock outlook for YEAREarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
Should you wait for a breakout in SELLAS Life Sciences Group Inc.Weekly Market Outlook & Safe Entry Trade Signal Reports - newser.com
Can SELLAS Life Sciences Group Inc. stock sustain revenue growthJuly 2025 Gainers & Precise Buy Zone Identification - newser.com
Using economic indicators to assess SELLAS Life Sciences Group Inc. potentialJuly 2025 EndofMonth & Real-Time Market Sentiment Alerts - newser.com
Understanding SELLAS Life Sciences Group Inc.’s price movementMarket Sentiment Summary & Daily Price Action Insights - newser.com
SELLAS Life Sciences Group Inc. stock prediction for this weekJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com
Is SELLAS Life Sciences Group Inc. showing signs of accumulation2025 Price Momentum & Reliable Volume Spike Trade Alerts - newser.com
Can SELLAS Life Sciences Group Inc. (RXK3) stock hold up in economic slowdownTrade Risk Assessment & High Win Rate Trade Alerts - newser.com
SELLAS Life Sciences Group Inc. stock trend forecastJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
What technical models suggest about SELLAS Life Sciences Group Inc.’s comeback2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Does SELLAS Life Sciences Group Inc. show high probability of reboundQuarterly Portfolio Report & Long-Term Investment Growth Plans - newser.com
Is SELLAS Life Sciences Group Inc. reversing from oversold territory2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
Is SELLAS Life Sciences Group Inc. stock attractive for retirement portfoliosMarket Risk Analysis & Growth Focused Entry Reports - newser.com
Will SELLAS Life Sciences Group Inc. (RXK3) stock test record highs in 2025July 2025 Fed Impact & Consistent Profit Focused Trading Strategies - newser.com
How SELLAS Life Sciences Group Inc. stock valuations compare to rivalsMarket Performance Summary & AI Forecasted Entry and Exit Points - newser.com
Does SELLAS Life Sciences Group Inc. fit your quant trading model2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Why Is SELLAS Life Sciences Stock Falling Today? - MSN
How institutional ownership impacts SELLAS Life Sciences Group Inc. stockInflation Watch & Breakout Confirmation Alerts - newser.com
Transcript : SELLAS Life Sciences Group, Inc.Special Call - MarketScreener
Sellas Life Sciences Group Inc. (SLS) Advances Cancer Pipeline with $31M Funding and Upcoming R&D Showcase - Insider Monkey
Sellas Life Sciences Group Inc Stock (SLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):